Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05841303Phase 4Unknown
Phase 4, randomised, single-blind trial of ascorbic acid (2 arms), sponsored by Cairo University. Primary endpoint: Gingival Thickness at 6 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05841303.